Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$210.76 - $249.51 $250,593 - $296,667
-1,189 Reduced 1.88%
62,192 $14.3 Million
Q4 2023

Feb 13, 2024

SELL
$214.88 - $256.94 $586,407 - $701,189
-2,729 Reduced 4.13%
63,381 $13.9 Million
Q3 2023

Nov 13, 2023

SELL
$211.82 - $248.24 $960,391 - $1.13 Million
-4,534 Reduced 6.42%
66,110 $14.9 Million
Q2 2023

Aug 04, 2023

BUY
$205.19 - $232.99 $67,507 - $76,653
329 Added 0.47%
70,644 $15.6 Million
Q1 2023

May 12, 2023

SELL
$212.99 - $276.17 $140,360 - $181,996
-659 Reduced 0.93%
70,315 $15.7 Million
Q4 2022

Feb 10, 2023

SELL
$205.95 - $280.43 $173,615 - $236,402
-843 Reduced 1.17%
70,974 $19.7 Million
Q3 2022

Nov 14, 2022

SELL
$203.3 - $244.17 $614,169 - $737,637
-3,021 Reduced 4.04%
71,817 $15 Million
Q2 2022

Aug 12, 2022

SELL
$174.81 - $241.14 $253,124 - $349,170
-1,448 Reduced 1.9%
74,838 $17.6 Million
Q1 2022

May 13, 2022

BUY
$166.16 - $213.96 $21,933 - $28,242
132 Added 0.17%
76,286 $13.7 Million
Q4 2021

Feb 11, 2022

SELL
$184.32 - $216.08 $212,336 - $248,924
-1,152 Reduced 1.49%
76,154 $16.5 Million
Q3 2021

Nov 12, 2021

SELL
$179.86 - $214.88 $407,023 - $486,273
-2,263 Reduced 2.84%
77,306 $14.3 Million
Q2 2021

Aug 13, 2021

SELL
$170.47 - $211.93 $194,506 - $241,812
-1,141 Reduced 1.41%
79,569 $14.3 Million
Q1 2021

May 07, 2021

BUY
$153.94 - $174.85 $82,050 - $93,195
533 Added 0.66%
80,710 $13.5 Million
Q4 2020

Feb 12, 2021

SELL
$101.87 - $151.79 $123,568 - $184,121
-1,213 Reduced 1.49%
80,177 $12.2 Million
Q3 2020

Nov 04, 2020

SELL
$99.9 - $121.13 $83,216 - $100,901
-833 Reduced 1.01%
81,390 $8.22 Million
Q2 2020

Aug 12, 2020

SELL
$92.74 - $125.82 $309,566 - $419,987
-3,338 Reduced 3.9%
82,223 $9.95 Million
Q1 2020

May 04, 2020

BUY
$79.39 - $115.35 $70,260 - $102,084
885 Added 1.05%
85,561 $8.11 Million
Q4 2019

Feb 05, 2020

BUY
$78.31 - $95.34 $44,480 - $54,153
568 Added 0.68%
84,676 $7.46 Million
Q3 2019

Nov 08, 2019

SELL
$74.85 - $85.99 $110,703 - $127,179
-1,479 Reduced 1.73%
84,108 $6.71 Million
Q2 2019

Aug 13, 2019

SELL
$76.06 - $120.81 $221,486 - $351,798
-2,912 Reduced 3.29%
85,587 $6.68 Million
Q1 2019

May 06, 2019

SELL
$107.15 - $126.84 $175,297 - $207,510
-1,636 Reduced 1.82%
88,499 $10.4 Million
Q4 2018

Feb 13, 2019

SELL
$101.4 - $128.73 $59,623 - $75,693
-588 Reduced 0.65%
90,135 $9.82 Million
Q3 2018

Nov 09, 2018

BUY
$113.81 - $129.46 $104,249 - $118,585
916 Added 1.02%
90,723 $11.6 Million
Q2 2018

Aug 08, 2018

BUY
$101.14 - $118.31 $114,389 - $133,808
1,131 Added 1.28%
89,807 $10.2 Million
Q1 2018

May 07, 2018

SELL
$107.21 - $151.94 $311,337 - $441,233
-2,904 Reduced 3.17%
88,676 $9.96 Million
Q4 2017

Feb 09, 2018

BUY
$118.58 - $151.28 $62,135 - $79,270
524 Added 0.58%
91,580 $13.5 Million
Q3 2017

Nov 09, 2017

BUY
$114.6 - $136.81 $10.4 Million - $12.5 Million
91,056
91,056 $10.7 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.3B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.